Page last updated: 2024-11-04

risedronic acid and Barrett Esophagus

risedronic acid has been researched along with Barrett Esophagus in 1 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Barrett Esophagus: A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.

Research Excerpts

ExcerptRelevanceReference
"This study examined Barrett's esophagus (BE) risk factors in veterans to determine the association between risk of BE and use of oral bisphosphonates."1.39Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans. ( Alsarraj, A; El-Serag, HB; Graham, DY; Kramer, JR; Lin, D; Parente, P; Ramsey, D; Rugge, M; Verstovsek, G, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lin, D1
Kramer, JR1
Ramsey, D1
Alsarraj, A1
Verstovsek, G1
Rugge, M1
Parente, P1
Graham, DY1
El-Serag, HB1

Other Studies

1 other study available for risedronic acid and Barrett Esophagus

ArticleYear
Oral bisphosphonates and the risk of Barrett's esophagus: case-control analysis of US veterans.
    The American journal of gastroenterology, 2013, Volume: 108, Issue:10

    Topics: Aged; Alendronate; Barrett Esophagus; Bone Density Conservation Agents; Case-Control Studies; Diphos

2013